MarshyOSScientific due diligence studio

Services

Five things we do. Each one opens.

Each can be bought as a call or as a written deliverable. Open one to see what it covers, what you receive, and a real example.

One asset, read end to end: how it works, what its trials showed, what the published evidence supports, and what the record does not establish.

What you receive

Mechanism and target, with the evidence behind each
Every trial of the asset, its results, and why any stopped
Safety signals from posted results and the label
A probability of reaching the next phase, with its range and a benchmark
What could not be established, each turned into a question for the sponsor

Real example / Manufacturing / Cell therapy

The class is administered as an infused product. Registered protocols in the public record do not specify a lot release step.

Not establishedNo release specification or product characterisation strategy exists in the public record for any programme in the class.

When a buyer would price two assets as equal, a gap like this is often the difference.

How it is structured

Three ways to work with us.

The usual startfrom £1,000

Evidence session

One hour on your asset, your question or your deck. Then a written summary of what the record supports and where it stops, within 24 hours.

Writtenquoted per scope

Full report

A single asset or a whole landscape, scoped with you at the start. Every claim numbered and cited, and a section of its own for what could not be established.

Returning clientsmember rates

Membership

A monthly plan built around what you need, whether that is calls, audits or reports.

Two conventions

The same page, written two ways.

Most diligence ends where the evidence ends, and fills the silence with reassurance. Ours says what the record holds, names what it does not, turns the gap into a question for the sponsor, and puts a probability beside it.

Section 4 / Chemistry, manufacturing and controls

1The class is administered as an infused product. Registered protocols in the public record do not specify a lot release step. [7]
2NOT ESTABLISHEDNo release specification or product characterisation strategy exists in the public record for any programme in the class.
3QUESTION FOR THE SPONSORProvide the release specification and the characterisation data behind it.
4PROBABILITY OF SUCCESSAn estimate of the programme reaching its next phase, with its range and the benchmark for comparable programmes, from our own models built on clinical trial data. A number to weigh, never a verdict.

Not sure which one? Start with a session.

Book an evidence session